Delivery Order SPE2DB20D9332-SPE2DB25FV3A9

Award Date 5/1/25
Potential Completion Date 5/22/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,943.10, is for the delivery of 4,567,991,932 units of the contraceptive implant Nexplanon 68 mg. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue...
This is a $6,291.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,556,217,484 units of the contraceptive implant NEXPLANON 68 MG and has a completion date of February 28, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,082.93, is for the delivery of 4,568,099,625 units of the contraceptive implant Nexplanon. The contract has no set-aside designation and is valid through May 16, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the delivery of 4,561,996,098 units of the contraceptive implant Nexplanon 68 mg. The contract has a ceiling value of $3,418.70 and a completion date of September 14, 2023. DMS Pharmaceutical Group holds a...
This is a firm fixed-price delivery order for $10,720.35 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,910,955 units of the contraceptive implant Nexplanon 68 mg and has an ultimate completion date of October 10, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $4,165.86, is for the delivery of 4,567,998,790 units of the Nexplanon 68 mg contraceptive implant. The award has an ultimate completion date of May 9, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
The Defense Logistics Agency (DLA) awarded a $10,720.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,566,777,703 units of the contraceptive implant NEXPLANON 68 MG. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products and medical supplies for the Department of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,379.52, is for the delivery of 4,558,294,944 units of the contraceptive implant Nexplanon. The contract is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This is a contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,429.38 firm fixed-price delivery order is for 4,565,089,397 units of the Nexplanon 68 MG contraceptive implant, with a period of performance through July 24, 2024. This award is under a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 held by DMS Pharmaceutical Group with the DLA, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,024.40 contract is for the delivery of 4,560,374,802 units of the contraceptive implant Nexplanon 68 mg. The delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
  • SPE2DB20D9332
    Indefinite Delivery Contract
  • SPE2DB20D9332-SPE2DB25FV3A9
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $13,886.20, is for the delivery of 4,568,160,659 units of the contraceptive implant Nexplanon. The award has a completion date of May 22, 2025 and is not set aside for any specific program. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting the medical supply needs of military health facilities worldwide.

Generated 7/31/25, 10:02 AM